Finance & valuation

Latest content

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams

05 August 2021

Investor interest in IP is about more than big money verdicts, claims Ocean Tomo transactions chief

Ten-figure awards in the patent space have caught capital’s attention, says Ocean Tomo's Ryan Zurek, but so has the IP market’s resilience in the face of economic turbulence

04 August 2021

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020

20 July 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key

19 July 2021

Confidence in Biden’s patent policies tumbles, according to new IAM survey

Second quarter panels report finds a marked increase in negative views about the administration, but fewer covid concerns and signs of higher royalty and sales prices

01 July 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP

29 June 2021

Via Licensing looks to extend its hold on audio space with next-gen patent pool

Company president Joe Siino tells IAM the pool operator has secured virtually all the key innovators behind MPEG-H to roll out a unified licensing solution

23 June 2021

In the mobile licensing world, US patent holdings do not have the power they did

Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process

17 June 2021

Another startup taps Aon for insurance-backed IP financing

Insurance giant, which recently announced a $400m IP fund, says it has a strong pipeline of lending deals in the works

17 June 2021

$2 billion deal shows growing sophistication of drug royalty sales

Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators

15 June 2021

Get unlimited access to all IAM content